80040923 - 14th International Sjogren's Symposium

14th International Sjogren's Symposium Banner

Date & Location
Wednesday, April 18, 2018, 10:00 AM - Saturday, April 21, 2018, 1:00 PM, Capital Hilton Hotel, Washington, DC

Target Audience
Family Practice, Multiple Specialties, Ophthalmology, Rheumatology


ABSTRACTS - Late Breaking!

Abstract deadlines and details are available online at https://sss2018.wixsite.com/sss2018 OR by clicking the link above.  Click Here to be redirected.

Sjögren’s syndrome (SS) is a complex autoimmune disease with a substantial health impact. Beyond the effects on individual health, SS and its complications have an estimated annual economic impact of ~$35 billion in the U.S. alone. It is a heterogeneous autoimmune disorder affecting >4,000,000 individuals in the U.S. Moisture-producing glands are universally targeted by the immune system, including salivary and lacrimal glands. Patients frequently develop serious complications that may include lymphoma, pulmonary dysfunction, neuropathy, and debilitating fatigue, among others. Diagnosing SS is a significant challenge and current therapies do little to interrupt pathogenic disease processes. Practitioners need to facilitate precision medicine practices in patient diagnosis, prognosis, therapeutic responses, and prevention to improve patient health outcomes and decrease morbidity.

This symposium is designed to facilitate precision medicine practices in all aspects of clinical care, including patient diagnosis, prognosis, therapeutic responses, and prevention. This pioneering conference specifically seeks to bring together leaders from the Sjögren's syndrome/autoimmune research community to enhance translation of novel discoveries into clinical practice. Practitioners must embrace the advances and new technology to ensure their practice evolves with the field, ultimately improving patient care, quality and safety. Based on recent research, literature review, faculty perception, expert opinion and reviews from previous activity evaluation and outcome survey data, this two and one half day activity will bring together science, technology, evidence-based medicine and leaders in the field to provide updates to an international audience, narrowing the gaps in knowledge.

Participants from academia, industry, and government funding agencies are expected to attend. We expect at least a third of our attendees to be from outside the U.S., in part because the Sjögren’s research community is traditionally very international in nature. Our invited speakers and abstract submissions reflect this international composition. We believe this is especially exciting and important for enhancing international recognition for scientific leadership.


This activity is intended for rheumatologists, ophthalmologists, oral medicine specialists, basic sciences researchers and other healthcare providers interested in Sjögren’s Syndrome and related disease states.

Please click here to see Program Schedule

THINGS TO SEE AND DO in Washington, DC: 


Methods of Payment:  We require full payment prior to the start of the activity.  On-site payments by credit card only.  The registration fee includes instructional materials, continental breakfasts, refreshment breaks and lunches.

Standard Registration by 3/31/18:

$725 Registration

$550 Student/PhD/Trainee/Resident*/Fellow*/Allied Health Professional

$550 RN/NP/PA

$550 Patient

Late Registration Fee after 3/31/18:

$825 Registration

$600 Student/PhD/Trainee/Resident*/Fellow*/Allied Health Professional

$600 RN/NP/PA

$600 Patient

*with verification of status

You will receive a confirmation by e-mail.  If you have not received it by April 12, 2018, call (410) 502-9634 to confirm that you are registered.  A transcript of attendance will be available upon attestation of your credit hours and submission of the post activity online evaluation.   

The Johns Hopkins University reserves the right to cancel or postpone any activity due to unforeseen circumstances.  In this event, the University will refund the registration fee but is not responsible for travel expenses.   Additionally, we reserve the right to change the venue to a comparable venue.  Under such circumstances registrants will be notified as soon as possible.


Please click on the image above for more information or click the registration link at the top of this page to register for this stand alone workshop.  You may add it to your ISSS conference registration.  This workshop is scheduled from 12:30 - 4:30 p.m. on Wednesday, April 18, 2018.  The ISSS general session will kick off at 5:30 p.m. 

Ultrasonography of the major salivary glands has emerged as an important technique for the evaluation of individuals with Sjögren’s syndrome. The structural abnormalities of the glands, elucidated with bedside ultrasonography, have a high degree of specificity for disease diagnosis and can be monitored as a parameter of glandular disease in clinical trials. This 4-hour course will feature key investigators who have pioneered and validated this imaging technique in Sjögren’s syndrome. The goal of the workshop is to provide participants with both up-to-date information on the utility and validity of ultrasonography in Sjögren’s syndrome and the opportunity to practice salivary gland ultrasonography on patient volunteers and scoring ultrasound examinations with direct faculty guidance.

Workshop Objectives:

  -Describe the utility of major salivary gland ultrasonography in the evaluation of patients with Sjögren’s syndrome and other forms of sialadenitis.

  -Perform major salivary gland ultrasonography on a patient with Sjögren’s syndrome, identifying the key abnormalities.

  -Score the observed abnormalities according to accepted international schema.

  -Recognize the utility of ultrasonography to guide fine needle and core needle biopsies of the major salivary glands in the evaluation of enlargement and solitary masses.


A $50 late fee applies to registrations received after 5:00 p.m. ET on April 12, 2018.  A handling fee of $50 will be deducted for cancellation.  An additional fee may apply for cancellation of other events, including workshops and social activities.  Refund requests must be received by fax or mail by April 12, 2018. No refunds will be made thereafter. Transfer of registration to another Johns Hopkins activity in lieu of cancellation is not possible. 


The syllabus will be accessible online and via your mobile device in the CloudCME App prior to the activity.  


Gala Information

Friday, April 20, 2018 | 6:30 – 10:30 p.m. | Cost: $100 per person

Decatur House, 748 Jackson Place NW, Washington, DC 20006

Website: https://www.whitehousehistory.org/decatur-house

Historic Decatur House is one of the oldest surviving homes in Washington, D.C., and one of only three remaining houses in the country designed by neoclassical architect Benjamin Henry Latrobe. Completed in 1818 for naval hero Stephen Decatur and his wife, Susan, the Federal Style house is prominently located across Lafayette Square from the White House. It was successively home to Henry Clay, Martin Van Buren and Edward Livingston, who collectively made Decatur House the unofficial residence of the Secretary of State from 1827 to 1833, each renting the house while they served in that post.

In 1836, John Gadsby and his wife Providence moved into the house and brought their house slaves. They built a two-story structure at the back which became the slave quarters for those workers, who previously lived in the main house. This structure remains as one of the few examples of slave quarters in urban areas. It is physical evidence of African Americans having been held "in bondage in sight of the White House.

The Decatur House is a short, 7-minute walk from the Capital Hilton. Just go south on 16th Street NW for two blocks, turn right on H Street NW and the Decatur House will be on your right.

  1. Outline current advances in the development of biomarkers for Sjogren's diagnosis and patient stratification, identification of genetic markers, and characterization of specific disease manifestations.
  2. Recognize quality of life issues for patients with Sjogren's syndrome.
  3. Describe the current clinical practice for the treatment of Sjogren's syndrome.
  4. Compare and contrast several outcome measures for clinical trials in Sjogren's syndrome.
  5. Evaluate the process of translating laboratory research into clinical trials for patients with Sjogren's syndrome.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Johns Hopkins University School of Medicine and the National Institutes of Health. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Johns Hopkins University School of Medicine designates this live activity general session for a maximum of 21.50 AMA PRA Category 1 Credits™ and optional workshop for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.